| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 2-Jan-09 | | Total Revenue | 121,470 | 134,725 | 139,818 | 146,600 | | Cost of Revenue | 82,333 | 93,253 | 95,654 | 99,858 | | | Gross Profit | 39,137 | 41,472 | 44,164 | 46,742 | | | Operating Expenses | | Research Development | 9,701 | 8,694 | 7,875 | 7,722 | | Selling General and Administrative | 18,869 | 20,309 | 21,490 | 12,474 | | Non Recurring | 34,500 |
-
|
-
| 14,578 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (23,933) | 12,469 | 14,799 | 11,968 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 134 | 606 | (182) | 3,317 | | Earnings Before Interest And Taxes | (23,799) | 13,075 | 14,617 | 15,285 | | Interest Expense | 4,895 | 4,930 | 4,889 | 3,260 | | Income Before Tax | (28,694) | 8,145 | 9,728 | 12,025 | | Income Tax Expense | (8,001) | 1,583 | 3,064 | 3,526 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (20,693) | 6,562 | 6,664 | 8,499 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (20,693) | 6,562 | 6,664 | 8,499 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($20,693) | $6,562 | $6,664 | $8,499 |
|
0.04% Nasdaq 
Income Statement
